{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T09:06:11Z","timestamp":1748855171576},"reference-count":13,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0378-6323.104672","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T15:19:46Z","timestamp":1355411986000},"page":"70","source":"Crossref","is-referenced-by-count":13,"title":["Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: A preliminary prospective randomized controlled study"],"prefix":"10.25259","volume":"79","author":[{"given":"AmrinderJ","family":"Kanwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RanjanaW","family":"Minz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davinder","family":"Parsad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keshavamurthy","family":"Vinay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tsuruta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norito","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NishaV","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.104672-1","first-page":"199","volume-title":"Pulse therapy with dexamethasone and cyclophosphamide in pemphigus","author":"Pasricha","year":"1984","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"http:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.104672-2","first-page":"351","volume-title":"Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus","author":"Amagai","year":"1999","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.104672-3","first-page":"439","volume-title":"Pemphigus in India","author":"Kanwar","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"http:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.104672-4","first-page":"1043","volume-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.104672-5","first-page":"529","volume-title":"ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus","author":"Abasq","year":"2009","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.104672-6","first-page":"358","volume-title":"Pulse Therapy with Dexamethasone in Reiter\u2032s Disease","author":"Pasricha","year":"1982","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"http:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.104672-7","first-page":"73","volume-title":"Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus","author":"Pasricha","year":"1988","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.104672-8","first-page":"228","volume-title":"Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus","author":"Kanwar","year":"2002","journal-title":"Dermatology"},{"key":"key-10.4103\/0378-6323.104672-9","doi-asserted-by":"crossref","unstructured":"Kanwar AJ, Tsuruta D, Vinay K, Koga H, Ishii N, Dainichi T, et al. Efficacy and safety of rituximab treatment in Indian pemphigus patients. J Eur Acad Dermatol Venereol 2011 [In Press].","DOI":"10.1111\/j.1468-3083.2011.04391.x"},{"key":"key-10.4103\/0378-6323.104672-10","first-page":"1070","volume-title":"Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission","author":"Kwon","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.104672-11","first-page":"2859","volume-title":"B-cell depletion immunotherapy in pemphigus: Effects on cellular and humoral immune responses","author":"Mouquet","year":"2008","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.104672-12","first-page":"790","volume-title":"Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus","author":"Saha","year":"2010","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.104672-13","first-page":"391","volume-title":"The usefulness of immunofluorescent tests in pemphigus patients in clinical remission","author":"David","year":"1989","journal-title":"Br J Dermatol"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:40:31Z","timestamp":1612658431000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/assessment-of-the-therapeutic-benefit-of-dexamethasone-cyclophosphamide-pulse-versus-only-oral-cyclophosphamide-in-phase-ii-of-the-dexamethasone-cyclophosphamide-pulse-therapy-a-preliminary-prospecti\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"alternative-id":["104672"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.104672","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}